Skip to content

Artificial Intelligence-led Dresden study aims at enhancing cancer diagnosis and treatment methods

Study in Dresden: Harnessing the Power of AI for Cancer Diagnosis and Therapy Improvement

Artificial intelligence (AI) being utilized to enhance knowledge and treatment methods for cancer...
Artificial intelligence (AI) being utilized to enhance knowledge and treatment methods for cancer in Dresden

Artificial Intelligence-led Dresden study aims at enhancing cancer diagnosis and treatment methods

The DECIPHER-M research project, funded by the Boehringer Ingelheim Foundation and the Federal Ministry of Education and Research (BMBF), is set to revolutionize the way we approach cancer treatment and diagnosis. The project, scheduled to run from this year until 2030, aims to last a total of five years and is estimated to receive a total funding of around nine million euros.

Led by Prof. Jakob Nikolas Kather, the project coordinator, DECIPHER-M involves scientists from several German cities, including Dresden, Aachen, Essen, Heidelberg, Mainz, and Munich. The project's long-term aim is to predict individual metastasis risk more precisely, allowing for preventive measures and improved treatment options for cancer patients.

The project's approach is multimodal, connecting various data sources such as tissue samples, X-ray images, and genetic information. This comprehensive understanding of cancer spread is expected to pave the way for new therapies and personalized treatment strategies for cancer.

DECIPHER-M is also leveraging the power of artificial intelligence (AI) to analyse and interpret the vast amounts of data collected. The goal is to enable earlier and more accurate diagnoses, ultimately improving the survival rates of cancer patients.

The Boehringer Ingelheim Foundation has committed an undisclosed amount for the project's five-year duration, while the BMBF is currently funding the project for three years with approximately 5.5 million euros. The total funding for the project is planned to be around nine million euros.

The DECIPHER-M research project is focused on understanding the spread of cancer cells, with the aim of creating a more personalized approach to cancer treatment. This groundbreaking project promises to bring about significant advancements in the field of oncology, offering hope for countless cancer patients around the world.

Read also:

Latest